NOVO: Godkendelse af Wegovy-pille. Spænding op til regnskab
133084 Helge Larsen/PI-redaktør 16/7 2026 19:42
Juli er tit en stille måned på aktiemarkederne. Det var ikke tilfældet sidste år, hvor Novo Nordisk nedjusterede, og aktien faldt 23 pct. på en dag. Flere hundredetusinde personer fulgte med på ProInvestor.com for at prøve at finde svar på situationen og fremtidsudsigterne. I år ser situationen anderledes ud - Novos Wegovy-pille brager af sted og er netop godkendt i EU. Nu venter vi på halvårsregnskabet - justerer de deres forventninger til året? Hvordan ser det ud med kapaciteten til at producere den eftertragtede pille?
17/7 2026 16:54 ProInvestorNEWS 0
133100 IQVIA prescription data for the latest week shows $NVO
's Oral Wegovy remains well ahead of $LLY
's Foundayo, despite a modest decline from last week.
Oral Wegovy recorded 147,500 prescriptions in week 27, down from 153,000 the previous week. Foundayo increased to 24,300 prescriptions in week 14 from 19,550.
For comparison, Oral Wegovy had already reached 113,354 prescriptions in its own week 14 after launch, showing how much stronger the launch has been.
Kilde: @Investseekers
's Oral Wegovy remains well ahead of $LLY
's Foundayo, despite a modest decline from last week.
Oral Wegovy recorded 147,500 prescriptions in week 27, down from 153,000 the previous week. Foundayo increased to 24,300 prescriptions in week 14 from 19,550.
For comparison, Oral Wegovy had already reached 113,354 prescriptions in its own week 14 after launch, showing how much stronger the launch has been.
Kilde: @Investseekers
133084 NOVO: Godkendelse af Wegovy-pille. Spænding op til regnskab
16/7 19:42 Helge Larsen/PI-redaktør 6
16/7 19:42 Helge Larsen/PI-redaktør 6